Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Pharmacol.

Sec. Neuropharmacology

Volume 16 - 2025 | doi: 10.3389/fphar.2025.1626907

This article is part of the Research TopicAdvances in Retinal Treatments: Addressing Visual Impairments and Neuronal TherapiesView all articles

α-Lipoic acid mitigates age-related macular degeneration via ferroptosis: integrative multi-omics and network pharmacology

Provisionally accepted
Yaqiong  ZhangYaqiong Zhang1,2Yuanyuan  ChenYuanyuan Chen1Chenglin  SunChenglin Sun2Fang  LiFang Li3Yin  ShenYin Shen1,4*
  • 1Eye Center, Renmin Hospital of Wuhan University, Wuhan, China
  • 2Xiangyang No.1 People’s Hospital, Hubei University of Medicine, Xiangyang, China
  • 3Department of Ophthalmology, Zhongnan Hospital of Wuhan University, Wuhan, China
  • 4Frontier Science Center for Immunology and Metabolism, and Medical Research Institute, Wuhan University, Wuhan, China

The final, formatted version of the article will be published soon.

Background Age-related macular degeneration (AMD) is a leading cause of irreversible vision loss among the elderly. α-Lipoic acid (ALA), a naturally occurring antioxidant and iron-chelator, has shown potential in modulating ferroptosis, but its mechanism in AMD remains unclear.Methods Network pharmacology, transcriptomic profiling, and machine learning were used to identify potential molecular targets of ALA in AMD. Core genes were identified through interaction network construction, functional enrichment analysis, and machine learning-based screening. Molecular docking and molecular dynamics simulations were performed to assess the binding affinity and stability between ALA and its predicted targets. In vivo validation was conducted using a sodium iodate (SI)-induced AMD mouse model, with retinal structure, function, oxidative stress, and gene expression evaluated through behavioral tests, histological staining, and qRT-PCR.We identified six ferroptosis-related core targets (AHCY, DHODH, MAPK1, MAPK8, NOS2, and HMOX1) of ALA implicated in AMD. Molecular docking revealed strong binding affinities between ALA and these six targets, with dynamic simulations confirming stable interactions, particularly with HMOX1 and MAPK1. In the SI-induced AMD mouse model, ALA significantly preserved retinal structure, maintained visual function, and reduced oxidative stress and iron accumulation. qRT-PCR confirmed that ALA exerted differential effects on the expression of the six genes, demonstrating a context-dependent regulatory mechanism.This study provides multi-level evidence that ALA protects against AMD by modulating ferroptosis-related pathways and restoring retinal structural integrity and functions. These findings warrant further investigation into the therapeutic potential of ALA in AMD.

Keywords: age-related macular degeneration (AMD), ferroptosis, α-Lipoic acid (ALA), Network Pharmacology, multi-omics

Received: 12 May 2025; Accepted: 09 Jul 2025.

Copyright: © 2025 Zhang, Chen, Sun, Li and Shen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Yin Shen, Eye Center, Renmin Hospital of Wuhan University, Wuhan, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.